Reprogramming engineered autologous T cells to overcome resistance in patients with Merkel cell carcinoma | Science Translational Medicine
TCR–T cells targeting Merkel cell carcinoma achieve tumor trafficking but limited responses, informing strategies to mediate effective tumor control.
